KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Receivables: 2014-2024

Historic Receivables for Exact Sciences (EXAS) over the last 11 years, with Dec 2024 value amounting to $274.9 million.

  • Exact Sciences' Receivables rose 7.90% to $337.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 13.83%. This contributed to the annual value of $274.9 million for FY2024, which is 12.04% up from last year.
  • According to the latest figures from FY2024, Exact Sciences' Receivables is $274.9 million, which was up 12.04% from $245.3 million recorded in FY2023.
  • In the past 5 years, Exact Sciences' Receivables registered a high of $274.9 million during FY2024, and its lowest value of $158.0 million during FY2022.
  • Its 3-year average for Receivables is $226.1 million, with a median of $245.3 million in 2023.
  • Per our database at Business Quant, Exact Sciences' Receivables spiked by 78.87% in 2020 and then declined by 27.05% in 2022.
  • Yearly analysis of 5 years shows Exact Sciences' Receivables stood at $233.2 million in 2020, then fell by 7.09% to $216.6 million in 2021, then dropped by 27.05% to $158.0 million in 2022, then spiked by 55.23% to $245.3 million in 2023, then increased by 12.04% to $274.9 million in 2024.